Evidence map›Paper›PMID 41339481›Full record

ArticleCellular & molecular immunology2026

MORF'ing of cGAS-STING to precisely tune radiosensitization and immune activation in hepatocellular carcinoma.

Tamalika Paul, Manali Powar, Irving Coy Allen

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Cellular & molecular immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Tamalika PaulDepartment of Biomedical Sciences and Pathobiology, VA-MD College of Veterinary Medicine, Blacksburg, VA, USA.
Manali PowarGraduate Program in Translational Biology, Medicine, and Health, Virginia Tech, Roanoke, VA, USA.
Irving Coy AllenDepartment of Biomedical Sciences and Pathobiology, VA-MD College of Veterinary Medicine, Blacksburg, VA, USA. icallen@vt.edu.

Funding

Optimization of High Frequency Irreversible Electroporation (H-FIRE) for tumor ablation and immune system activation in pancreatic cancer applicationsR01CA274439 · NCI · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI Irving C Allen · 2023 to 2026
$2.1M
Deploying Histotripsy Based Tumor Ablation Strategies to Treat Pancreatic CancerR01CA269811 · NCI · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI Irving C Allen · 2022 to 2026
$2.0M
NCI NIH HHS R01 CA269811NCI NIH HHS R01 CA274439
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41339481
PMCPMC12753624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.